How Parallel Capillary Electrophoresis Streamlines Genomic QC

Automated Capillary Electrophoresis for DNA and RNA Analysis

The Agilent Fragment Analyzer Systems are built around parallel capillary electrophoresis, a technology that processes 12 to 96 samples simultaneously with resolution adequate for DNA, RNA, and NGS library fragments. Run times fall under an hour, which changes how sequencing facilities schedule their QC pipelines.

Accuracy in fragment sizing and quantification is the operational payoff. For labs handling genomic DNA, PCR products, or cell-free DNA, the instrument removes the variability of manual gel interpretation and delivers reproducible data suitable for library normalization and downstream sequencing.

The system is primarily deployed in genomics labs, biotech R&D sites, and core sequencing facilities. Its throughput aligns with the scale of modern NGS runs, where rapid QC of libraries before clustering can prevent costly sequencing of failed samples.

China’s growing genomics sector — spanning agricultural biotech, clinical diagnostics, and population-scale sequencing projects — creates steady demand for automated electrophoresis. Procurement decisions here are driven by reproducibility, throughput, and integration with existing liquid-handling workflows.

The Fragment Analyzer reflects a broader shift: QC is no longer a post-hoc check but a procedural gate in high-throughput biology. Laboratories that automate this step gain confidence in their data before the expensive parts of the workflow begin.

Why it matters:
For labs scaling NGS or routine fragment analysis, this instrument reduces manual handling and standardizes QC. Buyers should evaluate throughput, consumables cost, and compatibility with their existing library prep protocols.

View Product →